SPG6 supports development of acute myeloid leukemia by regulating BMPR2-Smad-Bcl-2/Bcl-xl signaling

被引:3
|
作者
Chen, Jinliang [1 ]
Li, Chunling [1 ]
Zhan, Renhui [2 ]
Yin, Yancun [1 ]
机构
[1] Binzhou Med Univ, Sch Basic Med Sci, Taishan Scholar Immunol Program, 346 Guanhai Rd, Yantai 264003, Shandong, Peoples R China
[2] Binzhou Med Univ, Med & Pharm Res Ctr, Yantai 269003, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
SPG6; Acute myeloid leukemia; BMPR2; Apoptosis; HEREDITARY SPASTIC PARAPLEGIA; IMMUNOGLOBULIN-LIKE RECEPTORS; STEM-CELLS; CANCER DEVELOPMENT; TGF-BETA; PROTEINS; NIPA1; EXPRESSION; TARGET; BMPR2;
D O I
10.1016/j.bbrc.2018.04.220
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute myeloid leukemia (AML) is the most common acute leukemia affecting adults. To effectively treat AML, new molecular targets and therapeutic approaches must be identified. In silico analysis of several available databases of AML patients showed that the expression of Spastic Paraplegia 6 Protein (SPG6) significantly inversely correlates with the overall survival of AML patients. To determine whether SPG6 supports AML development, we employed an shRNA-encoding lentivirus system to inhibit SPG6 expression in human AML cells including NB4 and MV4-11 cells. Knockdown expression of SPG6 resulted in decreased cell growth and elevated apoptosis of these leukemia cells. Notably, the SPG6 deficiency resulted in higher BMPR2 expression indicating that BMPR2 signaling contributes to AML pathogenesis. Furthermore, SPG6 deficiency promoted phosphorylation of Smad1/5/9 and decreased transcription of BcI-2 and Bcl-xl. Our study suggests that SPG6 contributes to AML pathogenesis, and suggests that inhibition of SPG6 may be novel strategy for treating human AML. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:220 / 225
页数:6
相关论文
共 50 条
  • [41] Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia
    Findley, HW
    Gu, LB
    Yeager, AM
    Zhou, MX
    BLOOD, 1997, 89 (08) : 2986 - 2993
  • [42] Acute myeloid leukemia with BCL6 and KMT2A dual rearrangements
    Shen, Qiudan
    Hu, Shimin
    BLOOD, 2025, 145 (06) : 652 - 652
  • [43] Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia
    Kevin H. Lin
    Peter S. Winter
    Abigail Xie
    Cullen Roth
    Colin A. Martz
    Elizabeth M. Stein
    Gray R. Anderson
    Jennifer P. Tingley
    Kris C. Wood
    Scientific Reports, 6
  • [44] Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia
    Lin, Kevin H.
    Winter, Peter S.
    Xie, Abigail
    Roth, Cullen
    Martz, Colin A.
    Stein, Elizabeth M.
    Anderson, Grace R.
    Tingley, Jennifer P.
    Wood, Kris C.
    SCIENTIFIC REPORTS, 2016, 6
  • [45] High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-XL in chronic myeloid leukemia
    C M Lucas
    M Milani
    M Butterworth
    N Carmell
    L J Scott
    R E Clark
    G M Cohen
    S Varadarajan
    Leukemia, 2016, 30 : 1273 - 1281
  • [46] High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-XL in chronic myeloid leukemia
    Lucas, C. M.
    Milani, M.
    Butterworth, M.
    Carmell, N.
    Scott, L. J.
    Clark, R. E.
    Cohen, G. M.
    Varadarajan, S.
    LEUKEMIA, 2016, 30 (06) : 1273 - 1281
  • [47] Alteration of ROS production as well as bcl-2 and bcl-xl expression under development of cancer cells resistance
    Kalinina, E. V.
    Chernov, N. N.
    Saprin, A. N.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2006, : 466 - 466
  • [48] The non-apoptotic action of Bcl-xL: regulating Ca2+ signaling and bioenergetics at the ER-mitochondrion interface
    Williams, Abasha
    Hayashi, Teruo
    Wolozny, Daniel
    Yin, Bojiao
    Su, Tzu-Chieh
    Betenbaugh, Michael J.
    Su, Tsung-Ping
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2016, 48 (03) : 211 - 225
  • [49] Regulation of B cell apoptosis by Bcl-2 and Bcl-XL and its role in the development of autoimmune diseases (Review)
    Lopez-Hoyos, M
    Carrio, R
    Merino, J
    Merino, R
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1998, 1 (02) : 475 - 483
  • [50] The non-apoptotic action of Bcl-xL: regulating Ca2+ signaling and bioenergetics at the ER-mitochondrion interface
    Abasha Williams
    Teruo Hayashi
    Daniel Wolozny
    Bojiao Yin
    Tzu-Chieh Su
    Michael J. Betenbaugh
    Tsung-Ping Su
    Journal of Bioenergetics and Biomembranes, 2016, 48 : 211 - 225